A detailed history of Hrt Financial LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 28,418 shares of FLGT stock, worth $572,054. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,418
Holding current value
$572,054
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$19.6 - $25.06 $556,992 - $712,155
28,418 New
28,418 $617,000
Q2 2023

Aug 11, 2023

SELL
$28.52 - $40.7 $850,095 - $1.21 Million
-29,807 Reduced 84.11%
5,630 $208,000
Q1 2023

May 12, 2023

BUY
$29.39 - $36.27 $201,821 - $249,066
6,867 Added 24.04%
35,437 $1.11 Million
Q4 2022

Feb 10, 2023

BUY
$29.23 - $40.28 $835,101 - $1.15 Million
28,570 New
28,570 $850,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.